BR9508748A - Peptide use of the same antibodies cell lines hybridoma cell line pharmaceutical composition contraceptive vaccine process to detect autoimmune antibodies in a patient's serum test kit and diagnostic reagent - Google Patents

Peptide use of the same antibodies cell lines hybridoma cell line pharmaceutical composition contraceptive vaccine process to detect autoimmune antibodies in a patient's serum test kit and diagnostic reagent

Info

Publication number
BR9508748A
BR9508748A BR9508748A BR9508748A BR9508748A BR 9508748 A BR9508748 A BR 9508748A BR 9508748 A BR9508748 A BR 9508748A BR 9508748 A BR9508748 A BR 9508748A BR 9508748 A BR9508748 A BR 9508748A
Authority
BR
Brazil
Prior art keywords
antibodies
patient
pharmaceutical composition
test kit
diagnostic reagent
Prior art date
Application number
BR9508748A
Other languages
Portuguese (pt)
Inventor
Marcel Van Duin
Arij Jan Grootenhuis
Evert Johannes Bunschoten
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of BR9508748A publication Critical patent/BR9508748A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR9508748A 1994-08-22 1995-08-18 Peptide use of the same antibodies cell lines hybridoma cell line pharmaceutical composition contraceptive vaccine process to detect autoimmune antibodies in a patient's serum test kit and diagnostic reagent BR9508748A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94202392 1994-08-22
PCT/EP1995/003311 WO1996006113A1 (en) 1994-08-22 1995-08-18 New immunocontraceptive peptides

Publications (1)

Publication Number Publication Date
BR9508748A true BR9508748A (en) 1997-08-12

Family

ID=8217113

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9508748A BR9508748A (en) 1994-08-22 1995-08-18 Peptide use of the same antibodies cell lines hybridoma cell line pharmaceutical composition contraceptive vaccine process to detect autoimmune antibodies in a patient's serum test kit and diagnostic reagent

Country Status (10)

Country Link
EP (1) EP0777688A1 (en)
JP (1) JPH10505340A (en)
KR (1) KR970705578A (en)
CN (1) CN1158623A (en)
AU (1) AU3471395A (en)
BR (1) BR9508748A (en)
CA (1) CA2198265A1 (en)
FI (1) FI970744A0 (en)
HU (1) HUT77262A (en)
WO (1) WO1996006113A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19622289A1 (en) * 1996-05-23 1997-11-27 Schering Ag Zona Pellucida Proteins for contraception
AU3594397A (en) * 1996-07-03 1998-01-21 Zygam, Inc. Immunocontraceptive compositions containing sperm antigens, and methods of use
CN1291229A (en) 1998-02-19 2001-04-11 东弗吉尼亚医学院 Recombinant active human zona pellucida protein 3 (h2P3)
US7037663B2 (en) 1998-02-19 2006-05-02 Eastern Virginia Medical School Human zona pellucida protein 3 and uses thereof
CA2456821A1 (en) 2001-08-02 2003-02-13 Trinity Biomedical Technology Corporation Human zona pellucida proteins and methods of their use in diagnosing male infertility
CN101906163B (en) * 2009-06-05 2012-06-27 上海交通大学医学院 Immunocontraceptive synthetic peptide and immunocontraceptive chimeric peptide and application thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996297A (en) * 1987-10-07 1991-02-26 Zonagen, Inc. Recombinantly expressed rabbit zona pellucida polypeptides
JPH05500654A (en) * 1989-06-12 1993-02-12 アメリカ合衆国 Contraceptive vaccine based on cloned zona pellucida gene
IE912872A1 (en) * 1990-08-27 1992-03-11 Akzo Nv Human zona pellucida protein zp3
JPH05176771A (en) * 1991-11-29 1993-07-20 Tonen Corp Dna cording pig egg clear zone pzp-3
JPH0614784A (en) * 1991-11-29 1994-01-25 Tonen Corp Dna coding feline ovum clear zone fzp-3, its expressing peptide, and contraceptive vaccine containing the pfptide
JPH05336974A (en) * 1991-12-26 1993-12-21 Tonen Corp Dna capable of coding canine egg zona pellucida czp-3, czp-3-related peptide coded by the same dna and contraceptive vaccine containing the same peptide
JPH06179698A (en) * 1992-12-15 1994-06-28 Tonen Corp Peptide related to clear zone pzp-3 of pig egg
JPH06217777A (en) * 1993-01-29 1994-08-09 Tonen Corp Dna sequence-coding cat egg transparent zone fzp2

Also Published As

Publication number Publication date
FI970744A (en) 1997-02-21
FI970744A0 (en) 1997-02-21
CA2198265A1 (en) 1996-02-29
EP0777688A1 (en) 1997-06-11
HUT77262A (en) 1998-03-02
WO1996006113A1 (en) 1996-02-29
MX9701304A (en) 1998-05-31
JPH10505340A (en) 1998-05-26
AU3471395A (en) 1996-03-14
KR970705578A (en) 1997-10-09
CN1158623A (en) 1997-09-03

Similar Documents

Publication Publication Date Title
BR8906988A (en) TETRAPIPTIDIO, PEPTIDE, PHARMACEUTICAL COMPOSITION, PROCESS FOR USE OF PEPTIDE AND REAGENT FOR DIAGNOSIS
Rose Excretion of xanthurenic acid in the urine of women taking progestogen-oestrogen preparations
BR9406821A (en) Synthetic peptide immunogenic composition diagnostic kit useful for detecting HIV-specific antibodies in a test sample diagnostic kit for detecting HIV antigens in a test sample encoding nucleic acid molecule and antibody
ATE183514T1 (en) HUMAN PROTEIN P53 PEPTIDES FOR USE IN HUMAN CYTOTOXIC T CELL RESPONSE-INDUCING COMPOSITIONS AND HUMAN P53 PROTEIN SPECIFIC T LYMPHOCYTES
AU3045392A (en) Specimen containing block for use in the preparation of multi-specimen slides for immunohistologic procedures
IT8823166A0 (en) PROCEDURE AND DEVICE FOR THE QUANTITATIVE AND DIFFERENTIAL IN-DEPTH ANALYSIS OF SOLID SPECIMENS WITH THE USE OF TWO IONIC RAYS
FI962844A0 (en) T cell antigen receptor V region proteins and methods for their preparation
WO1995005604A3 (en) Methods for the diagnosis of alzheimer's disease
AU629121B2 (en) Test method and device to assay for total protein
BR9508748A (en) Peptide use of the same antibodies cell lines hybridoma cell line pharmaceutical composition contraceptive vaccine process to detect autoimmune antibodies in a patient's serum test kit and diagnostic reagent
EP0934427A4 (en) Rh blood group antigen compositions and methods of use
BR9708744A (en) Peptides consisting of 16 to 55 amino acid residues pharmaceutical composition diagnostic processes for detection of activated auto-reactive t cells and test kit
BR0009843A (en) Method of diagnosing transmissible spongy encephalopathies
KR950702308A (en) Diagnostic method for determining the expected delivery time and kit used for this purpose (DIAGNOSTIC METHOD FOR DETERMINING THE SUSCEPTIBILITY TO DELIVERY AND REAGENT KIT FOR USE THEREFOR)
EP0869177A3 (en) Human a- and b- platelet-derived growth factor receptor proteins and uses therefor.
BR9507451A (en) Pharmaceutical composition use of an amount of (i) a standardized antigen together with an amount of (ii) a polypeptide and product containing an amount of (i) a standardized antigen together with an amount of (ii) a polypeptide
Tanigaki et al. Common antigenic structures of HL-A antigens: II. Small fragments derived from papain-solubilized HL-A antigen molecules
IT1241154B (en) METHOD AND REAGENT COMPOSITION FOR THE DETERMINATION OF ALANINE AMININTRASPHERASE AND HBSAG ANTIGEN IN THE SAME BIOLOGICAL SAMPLE
ATE164311T1 (en) ORAL PHARMACEUTICAL COMPOSITIONS CONTAINING A PROTEIN OR PEPTIDES, AN ANTIBODIES AND POLYMER SPHERES
DE69627942D1 (en) Polypeptides and reagents for measuring components of a living body through their use
BR9607230A (en) Dissolution test vessel and use of the vessel in the dissolution test of a pharmaceutical formulation
Benagiano et al. Biosynthesis of human chorionic gonadotrophin in vitro: Incorporation of [14C] L-leucine
Lennon et al. Immunological responses of guinea pigs to a synthetic autoantigen of brain
ITMI950702A0 (en) DIAGNOSTIC TEST FOR THE RAPID AND SAFE DETECTION OF A CLINICAL MARKER FOR THE DIAGNOSIS OF MENOPAUSE IN WOMEN
NZ220485A (en) Peptides of 4-10 amino-acids and use in test kits for detecting aids antibodies

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law